PEARL study results have not been revealed yet (to the best of my knowledge): PEARL Study Results (progress)
2 Likes
RapAdmin
split this topic
#43
Interesting - is this common practice and safe, besides possible interactions w other drugs?
1 Like
Doctors don’t generally recommend it, read more here: Improve Bioavailability of Rapamycin (2)
1 Like
It becomes a problem if you have other medications that interact with grapefruit. Otherwise it’s fine IMHO.
1 Like
KarlT
#47
Some medications that can interact with grapefruit include:
-
Cholesterol drugs: Atorvastatin (Lipitor), lovastatin (Mevacor), and simvastatin (Zocor)
-
High blood pressure drugs: Felodipine (Plendil), nifedipine (Procardia), and nisoldipine (Sular)
-
Heart arrhythmia drugs: Amiodarone (Cordarone) and disopyramide (Norpace)
-
Anti-anxiety drugs: Buspirone
-
Blood thinners: Eliquis (apixaban), Plavix (clopidogrel), and Xarelto (rivaroxaban)
-
Antidepressants: Sertraline (Zoloft)
4 Likes
Raquel
#48
Interesting the vascular effect of rapamycin…
A Japanese team (Ozeki et al. 2025) published a study that may help on this matter. The results were good considering that the vascular anomalies were “intractable”: “Sirolimus treatment for intractable vascular anomalies (SIVA): An open‐label, single‐arm, multicenter, prospective trial”
(…) “Patients received sirolimus tablets or granules (Rapalimus Tablet or Granules, Nobelpharma Co., Ltd., Tokyo, Japan) orally once a day, either after meals or on an empty stomach. The initial dose of oral sirolimus tablets in patients weighing ≥30 kg was 2 mg/day. The starting dose of sirolimus granules in patients ≥30 kg was 0.7 g, equivalent to 1.4 mg of sirolimus, and the initial dose in patients <30 kg was calculated based on the patient’s age and weight (Table [1]. Dose adjustments were made according to sirolimus trough concentrations measured in the second week, to achieve a target concentration of 5–15 ng/mL.”
(I have doubts about rapa intake with or without food)
2 Likes